Telomir Pharmaceuticals Inc <TELO.O>: Maxim Group initiates coverage with buy rating; target price $4
TELO•Related News
Warsh’s reluctant turn restarts Fed war
TLT•
Lucid partners with Bolt to deploy at least 25,000 autonomous vehicles in Europe
LCID•
Nasdaq Trade Halt <LSTA.O> Halt News Pending at 07:55 AM
LSTA•
King Charles warns AI leaders of existential risks if technology falls into wrong hands
QQQ•
Moving iMage Technologies schedules fiscal Q4 2026 earnings call
MITQ•